Data / Federal awards / NAICS 325412 / PARTNER THERAPEUTICS, INC.
PARTNER THERAPEUTICS, INC.: 10 federal contract awards, $124.5 million obligated (FY2024 to FY2027)
PARTNER THERAPEUTICS, INC. (UEI J33MSDBJZMC6), Lexington, MA, received 10 federal prime contract awards with $124.5 million obligated in fiscal years 2024 to 2027, from 2 agencies under 4 NAICS codes. Its largest buyer is Department of Health and Human Services ($124.3 million) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- J33MSDBJZMC6UEI
- Lexington, MALocation
- Small BusinessBusiness size
- 10Contract awards
- $124.5 millionObligated
- 2023-11-28First action in window
- 2026-09-15Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | 7 | $111.6 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $13 million |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $0 |
| 325414 | Biological Product (except Diagnostic) Manufacturing | 1 | $0 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 5 | $124.3 million |
| Department of Veterans Affairs | 5 | $235,477 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $35.2 million |
| FY2025 | $39.1 million |
| FY2026 | $50.2 million |
Contract awards
All 10 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50323F80027 | Department of Health and Human Services | Delivery Order | 325412 | LEUKINE 250MCG VIL INJ (5PKG) | $111,315,080 | $133,514,342 | September 26, 2023 | March 29, 2027 | Lexington, MA | usaspending.gov |
| 75A50124C00061 | Department of Health and Human Services | Definitive Contract | 541715 | PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, | $12,990,717 | $12,990,717 | September 30, 2024 | March 31, 2028 | Lexington, MA | usaspending.gov |
| 36C24626N0782 | Department of Veterans Affairs | Delivery Order | 325412 | EMERG. BIZENGRI MEDS FOR VETERAN | $72,563 | $72,563 | June 16, 2026 | July 10, 2026 | Lexington, MA | usaspending.gov |
| 36C24626N1034 | Department of Veterans Affairs | Delivery Order | 325412 | BIZENGRI MEDICATION | $72,362 | $72,362 | September 4, 2026 | September 11, 2026 | Lexington, MA | usaspending.gov |
| 36C24626N0690 | Department of Veterans Affairs | Delivery Order | 325412 | EMERGENCY BIZENGRI MEDS. FOR VETERAN | $54,271 | $54,271 | May 5, 2026 | May 19, 2026 | Lexington, MA | usaspending.gov |
| 36C24626N0637 | Department of Veterans Affairs | Delivery Order | 325412 | EMERGENCY BIZENGRI MEDS FOR VETERAN | $36,281 | $36,281 | April 10, 2026 | April 24, 2026 | Lexington, MA | usaspending.gov |
| 36F79723D0171 | Department of Veterans Affairs | FSS | 325412 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | $0 | $15,835,899 | August 15, 2023 | usaspending.gov | ||
| 75A50322F80018 | Department of Health and Human Services | Delivery Order | 325412 | LEUKINE 250MCG/VIL INJ | $0 | $59,026,989 | July 25, 2022 | March 29, 2024 | Boston, MA | usaspending.gov |
| 75A50123C00064 | Department of Health and Human Services | Definitive Contract | 541714 | R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOV | $0 | $748,039 | September 25, 2023 | January 30, 2026 | Lexington, MA | usaspending.gov |
| HHSO10033002T | Department of Health and Human Services | Delivery Order | 325414 | IGF::OT::IGF TASK ORDER 2 UNDER RFP-12-100-SOL-00016 | $0 | $13,943,972 | September 30, 2013 | September 29, 2018 | Bridgewater, NJ | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Open opportunities under NAICS 325412
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541714
Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.